Armenia, D., Di Carlo, D., Calcagno, A., Vendemiati, G., Forbici, F., Bertoli, A., et al. (2016). Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, dkw512 [10.1093/jac/dkw512]. Dettagli
10.1093/jac/dkw512
CitazioneArmenia, D., Di Carlo, D., Calcagno, A., Vendemiati, G., Forbici, F., Bertoli, A., et al. (2016). Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, dkw512 [10.1093/jac/dkw512].Data2016-12-20idPUBBLICAZIONE_302355TipologiaArticolo su rivistaSSDSettore MED/07 - Microbiologia e Microbiologia ClinicaTutti gli AutoriPre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimentipologiaArmenia, D; Di Carlo, D; Calcagno, A; Vendemiati, G; Forbici, F; Bertoli, A; Berno, G; Carta, S; Continenza, F; Fedele, V; Bellagamba, R; Cicalini, S; Ammassari, A; Libertone, R; Zaccarelli, M; Ghisetti, V; Andreoni, M; Ceccherini-Silberstein, F; Bonora, S; Di Perri, G; Antinori, A; Perno, Cf; Santoro, MM